6.
De Meerleer G, Berghen C, Briganti A, Vulsteke C, Murray J, Joniau S
. Elective nodal radiotherapy in prostate cancer. Lancet Oncol. 2021; 22(8):e348-e357.
DOI: 10.1016/S1470-2045(21)00242-4.
View
7.
Zarifmahmoudi L, Ghorbani H, Sadri K, Tavakkoli M, Keshvari M, Salehi M
. Sentinel Node Biopsy in Urothelial Carcinoma of the Bladder: Systematic Review and Meta-Analysis. Urol Int. 2019; 103(4):373-382.
DOI: 10.1159/000497310.
View
8.
Liskamp C, Donswijk M, van der Poel H, Schaake E, Vogel W
. Nodal recurrence patterns on PET/CT after RTOG-based nodal radiotherapy for prostate cancer. Clin Transl Radiat Oncol. 2020; 22:9-14.
PMC: 7056599.
DOI: 10.1016/j.ctro.2020.02.006.
View
9.
De Bruycker A, De Bleser E, Decaestecker K, Fonteyne V, Lumen N, De Visschere P
. Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates. Eur Urol. 2018; 75(5):826-833.
DOI: 10.1016/j.eururo.2018.10.044.
View
10.
Biau J, Lapeyre M, Troussier I, Budach W, Giralt J, Grau C
. Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. Radiother Oncol. 2019; 134:1-9.
DOI: 10.1016/j.radonc.2019.01.018.
View
11.
Jensen K, Overgaard M, Grau C
. Morbidity after ipsilateral radiotherapy for oropharyngeal cancer. Radiother Oncol. 2007; 85(1):90-7.
DOI: 10.1016/j.radonc.2007.06.005.
View
12.
Shi X, Feng D, Li D, Zhang F, Wei W
. The Role of Lymph Node Dissection for Non-Metastatic Renal Cell Carcinoma: An Updated Systematic Review and Meta-Analysis. Front Oncol. 2022; 11:790381.
PMC: 8790094.
DOI: 10.3389/fonc.2021.790381.
View
13.
Longton E, Lawson G, Bihin B, Mathieu I, Hanin F, Deheneffe S
. Individualized Prophylactic Neck Irradiation in Patients with cN0 Head and Neck Cancer Based on Sentinel Lymph Node(s) Identification: Definitive Results of a Prospective Phase 1-2 Study. Int J Radiat Oncol Biol Phys. 2020; 107(4):652-661.
DOI: 10.1016/j.ijrobp.2020.03.021.
View
14.
Castelo M, Hu S, Dossa F, Acuna S, Scheer A
. Comparing Observation, Axillary Radiotherapy, and Completion Axillary Lymph Node Dissection for Management of Axilla in Breast Cancer in Patients with Positive Sentinel Nodes: A Systematic Review. Ann Surg Oncol. 2020; 27(8):2664-2676.
DOI: 10.1245/s10434-020-08225-y.
View
15.
Schiller K, Stohrer L, Dusberg M, Borm K, Devecka M, Vogel M
. PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy. Eur Urol Oncol. 2020; 4(1):73-83.
DOI: 10.1016/j.euo.2020.04.004.
View
16.
Spratt D, Vargas H, Zumsteg Z, Pernicka J, Osborne J, Pei X
. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol. 2016; 71(1):37-43.
PMC: 5571898.
DOI: 10.1016/j.eururo.2016.07.043.
View
17.
Spencer C, Gay H, Haughey B, Nussenbaum B, Adkins D, Wildes T
. Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life. Cancer. 2014; 120(24):3994-4002.
PMC: 4257883.
DOI: 10.1002/cncr.28938.
View
18.
Boileau J, Poirier B, Basik M, Holloway C, Gaboury L, Sideris L
. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2014; 33(3):258-64.
DOI: 10.1200/JCO.2014.55.7827.
View
19.
Balaya V, Guani B, Bonsang-Kitzis H, Delomenie M, Ngo C, Montero Macias R
. [Sentinel lymph node biopsy in early-stage cervical cancer: current state of art]. Bull Cancer. 2019; 107(6):696-706.
DOI: 10.1016/j.bulcan.2019.06.011.
View
20.
Murthy V, Maitre P, Kannan S, Panigrahi G, Krishnatry R, Bakshi G
. Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial. J Clin Oncol. 2021; 39(11):1234-1242.
DOI: 10.1200/JCO.20.03282.
View